Pilgrim Cancer Center is categorized under Internal Medicine Doctors in Mount Pleasant, TX and active since 2008.
Pilgrim Cancer Center was established in 2008, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6223100 by the NAICS.
If you are seeking more information, feel free to contact Ernest Cochran at the company’s single location by writing to 2101 Mulberry Avenue, Mount Pleasant, Texas TX 75455 or by phoning (903) 572-2134. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pilgrim Cancer Center |
| Contact Person: | Ernest Cochran |
| Address: | 2101 Mulberry Avenue, Mount Pleasant, Texas 75455 |
| Phone Number: | (903) 572-2134 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6223100 |
| Share This Business: |
Pilgrim Cancer Center was started in 2008 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6223100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Ernest Cochran for inquiries that concern Pilgrim Cancer Center by calling the company number (903) 572-2134, as your correspondence is most welcome. Additionally, the physical location of the single location of Pilgrim Cancer Center can be found at the coordinates 33.17656,-94.97308 as well as the street address 2101 Mulberry Avenue in Mount Pleasant, Texas 75455.
For its online presence, you may visit Pilgrim Cancer Center’s website at and engage with its social media outlets through on Twitter and on Facebook.